Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.3K Buy
58
+5
+9% +$1.04K ﹤0.01% 926
2026
Q1
$11.9K Hold
53
﹤0.01% 839
2025
Q4
$12.7K Hold
53
﹤0.01% 802
2025
Q3
$14.5K Hold
53
﹤0.01% 793
2025
Q2
$13.6K Hold
53
﹤0.01% 778
2025
Q1
$11.8K Hold
53
﹤0.01% 762
2024
Q4
$12K Hold
53
﹤0.01% 754
2024
Q3
$12.2K Hold
53
﹤0.01% 748
2024
Q2
$10.1K Hold
53
﹤0.01% 745
2024
Q1
$10.4K Buy
+53
New +$9.71K ﹤0.01% 500

Other funds holding RMD

LRI Investments's RMD Position: Q2 2026 in Review

LRI Investments increased its ResMed (RMD) stake by 9.4% in Q2 2026, buying an estimated $1.04K and bringing the position to 58 shares worth $11.3K. The position accounts for ﹤0.01% of the portfolio, ranked #926.

LRI Investments first reported a position in RMD in Q1 2024 and has held it in 10 quarters since. The position peaked at $14.5K in Q3 2025. 139 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • LRI Investments held 58 shares of ResMed worth $11.3K as of Q2 2026.
  • LRI Investments bought 5 ResMed shares in Q2 2026, an estimated $1.04K.
  • ResMed made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #926 holding.
  • LRI Investments first reported a position in ResMed in Q1 2024 and has held it in 10 quarters since.
  • LRI Investments's ResMed position peaked at $14.5K in Q3 2025.
  • 139 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.